CSPC Innovation Pharmaceutical (300765.SZ) completed a repurchase of 12.002 million shares at a cost of 321 million yuan.
New Noble (300765.SZ) announcement, as of September 20, 2024, the company has completed the share repurchase through special certificates...
CSPC Innovation Pharmaceutical (300765.SZ) announced that as of September 20, 2024, the company repurchased 12.002 million shares of the company through a special securities account for share repurchase using centralized bidding trading, accounting for 0.85% of the company's current total share capital. The highest transaction price was 34.99 yuan per share, the lowest transaction price was 18.68 yuan per share, and the total amount paid was 321 million yuan (excluding transaction costs). The buyback period has expired, and the buyback plan has been completed.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


